Sp. Weisberg et Gb. Kaplan, Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL/6 mouse, NEUROSCI L, 264(1-3), 1999, pp. 89-92
We examined the effects of adenosine antagonists on the development of morp
hine sensitization in C57BL/6 mice. Adenosine antagonists or vehicle were r
epeatedly co-administered intraperitoneally with morphine (10 mg/kg, s.c,)
to mice once every other day for 9 days. Two days later, a 10 mg/kg morphin
e-only challenge was administered to each group. Consistent with sensitizat
ion, mice receiving morphine alone developed enhanced ambulatory activity r
esponses to subsequent morphine administrations and, upon morphine-only cha
llenge, had a significantly greater response to morphine than vehicle pretr
eated animals. The nonselective adenosine antagonist, caffeine, at 10 and 2
0 mg/kg hut not at 5 mg/kg, attenuated the development of sensitization dur
ing co-administration with morphine and also following morphine-only challe
nge. The adenosine Al selective antagonist 1,3-dipropyl-8-(2-amino-4-chloro
phenyl)-xanthine (PACPX), at 0.001 and 0.002 mg/kg but not at 0.2 mg/kg, si
milarly attenuated the development of morphine sensitization. We propose a
mechanism which involves an adenosine receptor role in the mesolimbic dopam
ine system. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.